Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China
· Delayed Price · Currency is CNY 17.77
-0.21 (-1.17%)
Mar 11, 2026, 11:29 AM CST
SHA:603079 Revenue
Zhejiang Shengda Bio-Pharm had revenue of 197.50M CNY in the quarter ending June 30, 2025, a decrease of -1.07%. This brings the company's revenue in the last twelve months to 839.82M, up 6.01% year-over-year. In the year 2024, Zhejiang Shengda Bio-Pharm had annual revenue of 827.40M with 13.75% growth.
Revenue (ttm)
839.82M
Revenue Growth
+6.01%
P/S Ratio
4.01
Revenue / Employee
811.42K
Employees
1,035
Market Cap
3.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 827.40M | 100.00M | 13.75% |
| Dec 31, 2023 | 727.41M | -10.61M | -1.44% |
| Dec 31, 2022 | 738.02M | -51.71M | -6.55% |
| Dec 31, 2021 | 789.73M | -77.58M | -8.95% |
| Dec 31, 2020 | 867.31M | 348.16M | 67.06% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Lifestrong Pharmacy | 278.31M |
| Jiangxi Synergy Pharmaceutical | 825.20M |
| Lionco Pharmaceutical Group | 430.61M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 784.62M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Hunan Hansen Pharmaceutical | 1.05B |
| Guizhou Yibai Pharmaceutical | 1.91B |
| Anhui Fengyuan Pharmaceutical | 4.15B |